Finance
Results: 12313-12324 of 49295

Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Universal Music Group N.V. to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025




